The effect of time from biopsy to radical prostatectomy on adverse pathologic outcomes
Open Access
- 1 March 2019
- journal article
- research article
- Published by Taylor & Francis in Research and Reports in Urology
- Vol. ume 11, 53-60
Abstract
Objective: To assess the impact of time between prostate cancer diagnosis on biopsy and definitive intervention with radical prostatectomy (RP) in regard to adverse pathologic outcomes using a large multi-surgeon database. Materials and methods: We retrospectively reviewed 2,728 patients who underwent RP between 2005 and 2014. Patients were stratified according to biopsy Grade Group (GG). Pathologic outcomes were evaluated for patients with Results: In total 2,310 patients met the inclusion criteria. Median time from biopsy to surgery was 83 days (range: 61–109 days). No difference was observed for patients in any risk category regarding the adverse pathologic outcomes, including GG upgrade from biopsy to prostatectomy, presence of EPE, SVI, positive surgical margins, and positive lymph node involvement, with delays of up to 6 months between biopsy and RP. Surgical margins were positive in 25% of cases with pT2 disease and 50.2% of cases with pT3 and greater disease. EPE and SVI were present in 24.5% and 7.5% of specimens, respectively. Conclusion: Surgical delays of up to 6 months following prostate biopsy were not associated with an increased risk of GG upgrading, EPE, SVI, positive surgical margins, or lymph node involvement.Keywords
This publication has 24 references indexed in Scilit:
- Immediate Versus Delayed Radical Prostatectomy: Updated Outcomes Following Active Surveillance of Prostate CancerEuropean Urology, 2015
- Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomesThe Prostate, 2015
- Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate CancerJAMA, 2015
- Timing of Curative Treatment for Prostate Cancer: A Systematic ReviewEuropean Urology, 2013
- Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH databaseThe Prostate, 2012
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary GradesEuropean Urology, 2012
- Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysisBJU International, 2011
- Delay of Surgery in Men With Low Risk Prostate CancerJournal of Urology, 2011
- Delay of Radical Prostatectomy and Risk of Biochemical Progression in Men With Low Risk Prostate CancerJournal of Urology, 2006
- Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?BJU International, 2005